SGC-CBP30

response biomarkers — cross-omics
Drug responseDRUG → PROTEIN-MSCell line8-(3-chloro-4-methoxy-phenethyl)-4-(3,5-dimethyl-isoxazol-4-yl)-9-(2-(morpholin-4-yl)-propyl)-7,9-diaza-bicyclo[4.3.0]nona-1(6),2,4,7-tetraene

Across CCLE and GDSC cell-line panels, response to SGC-CBP30 is significantly associated with the protein abundance of multiple proteins, with OVARY cell lines showing a particularly strong set of associations.

The most reproducible SGC-CBP30 response-associated proteins across cancer lineages are LMNA, EEF1E1, and OGDH, each associated with drug response in up to 8 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, SGC-CBP30 response versus LMNA protein abundance in OVARY (Pearson r = -0.42).

Protein abundance biomarkers of SGC-CBP30 response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
OVARYLMNA →-1.436-0.288.031.02138
LARGE_INTESTINEEEF1E1 →+0.754+0.492.008.00138
LIVEROGDH →-0.733-0.639.008<.00137
LUNG_SCLCRRBP1 →-1.175-0.441.035.04936
LUNG_SCLCOS9 →-0.958-0.519.049.01727
STOMACHENDOD1 →-2.109-0.481.006.01236
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

SGC-CBP30 response vs LMNA — OVARY

Per-cell-line scatter of SGC-CBP30 response vs LMNA protein abundance in OVARY.

Explore this scatter interactively →

Exploration